Informations sur le produit
KDOAM 21 is a demethylase inhibitor that inhibits the activity of histone-demethylases. It has been shown to inhibit methylation of histones H3 and H4, which are important for gene silencing. KDOAM 21 is being developed as a potential treatment for cancer.